Delivery Order SPE2DB25D3008-SPE2DB25FRDDA
Award Date 9/3/25
Potential Completion Date 9/24/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a prescription medication used in the treatment of prostate cancer. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and a firm fixed price structure. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 12, 2025. The award was made through open competition with...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orgovyx 120 mg, a pharmaceutical product used in oncology treatment. This delivery order, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award utilized no set-aside designation, indicating it was competitively awarded....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,385.52, is for the delivery of the medication Orgovyx 120 mg tablet, a prostate cancer treatment. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 6, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The contract ceiling value is $1,385.52, with an ultimate completion date of September 10, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product used in hormone-based cancer treatment. Issued on July 21, 2025, with an ultimate completion date of August 11, 2025, this firm fixed-price delivery order represents a routine pharmaceutical supply transaction under a competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $16,626.24 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on September 9, 2025, with a completion date of September 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...